Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Wells

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1988
Effects of N-acetylcysteine on fetal development and on phenytoin teratogenicity in miceM Wong, P G Wells
Toxicology and Applied Pharmacology|April 1, 1994
In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesisL Liu, P G Wells
Toxicology and Applied Pharmacology|September 1, 1995
Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatantL Liu, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)M Wong, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediateR R Arlen, P G Wells
Cancer Research|April 1, 1996
Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyreneP M Kim, P G Wells
Journal of Chromatography|September 28, 1984
Rapid and sensitive assays using high-performance liquid chromatography to measure the activities of phase II drug metabolising enzymes: glucuronyl transferase and sulfotransferaseE C To, P G Wells
Advances in Experimental Medicine and Biology|January 1, 1986
Effect of diethyl ether on the bioactivation, detoxification, and hepatotoxicity of acetaminophen in vitro and in vivoP G Wells, E C To
Free Radical Biology & Medicine|January 23, 1999
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicityL M Winn, P G Wells
Toxicology and Applied Pharmacology|March 1, 1995
Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 miceW K Yu, P G Wells
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1988
Effects of N-acetylcysteine on fetal development and on phenytoin teratogenicity in miceM Wong, P G Wells
Toxicology and Applied Pharmacology|April 1, 1994
In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesisL Liu, P G Wells
Toxicology and Applied Pharmacology|September 1, 1995
Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatantL Liu, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)M Wong, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediateR R Arlen, P G Wells
Cancer Research|April 1, 1996
Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyreneP M Kim, P G Wells
Journal of Chromatography|September 28, 1984
Rapid and sensitive assays using high-performance liquid chromatography to measure the activities of phase II drug metabolising enzymes: glucuronyl transferase and sulfotransferaseE C To, P G Wells
Advances in Experimental Medicine and Biology|January 1, 1986
Effect of diethyl ether on the bioactivation, detoxification, and hepatotoxicity of acetaminophen in vitro and in vivoP G Wells, E C To
Free Radical Biology & Medicine|January 23, 1999
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicityL M Winn, P G Wells
Toxicology and Applied Pharmacology|March 1, 1995
Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 miceW K Yu, P G Wells
Pageof 8